[Pegylated interferons: preliminary review of their pharmacokinetic characteristics].
Azanza Perea
J R
JR
Servicio de Farmacología Clínica, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, Avda. Pío XII, s/n, 31008 Pamplona. frazanza@unav.es
D000818:Animals; D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000493:pharmacokinetics* / Q000494:pharmacology; D016899:Interferon-beta; D007372:Interferons / Q000493:pharmacokinetics* / Q000494:pharmacology; D011092:Polyethylene Glycols / Q000493:pharmacokinetics* / Q000494:pharmacology; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D016899:Interferon-beta; D007372:Interferons; C417083:peginterferon alfa-2b; C428112:peginterferon beta-1a; C100416:peginterferon alfa-2a